Muken Ross 4

What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold a total of 5,024 shares in two open-market transactions to satisfy tax withholding tied to recently vested restricted stock units. The insider disposed of 2,600 shares on 2026-04-06 at a weighted average price of $4.85 (≈ $12,603) and 2,424 shares on 2026-04-07 at a weighted average price of $4.87 (≈ $11,801), for combined proceeds of about $24,404. These sales were routine tax-withholding transactions rather than discretionary purchases.

Key Details

• Transaction dates: 2026-04-06 (2,600 shares @ $4.85, proceeds ≈ $12,603) and 2026-04-07 (2,424 shares @ $4.87, proceeds ≈ $11,801).
• Weighted-average prices reported; underlying trade price ranges: 4/6 sales ranged $4.6150–$4.95, 4/7 sales ranged $4.77–$4.98 (the filer can provide per-price breakdown on request).
• Purpose: Sales executed to satisfy tax withholding on restricted stock units that vested April 2–3, 2026 (Footnote F1).
• Trading plan: Sales were effected under a pre-established Rule 10b5-1 plan and were non-discretionary (Footnote F1).
• Shares owned after transaction: not reported in the provided filing details.
• Filing: Form 4 filed 2026-04-08 covering transactions on April 6–7; no indication in the record provided that the filing was late.

Context

• These sales are tax-withholding dispositions following RSU vesting, which are common and typically do not signal a change in an insider's view of the company. Purchases generally carry stronger signals of insider confidence than routine withholding sales.